AGAP2 and non-small cell lung carcinoma: To evaluate the diagnostic efficiency of exosomal lncRNA TBILA and AGAP2-AS1 in NSCLC patients with different subtypes and early stage, ROC curve analysis was plotted to determine the AUC, sensitivity and specificity.